Parkinson's patients get new hope: group therapy targets anxiety and depression

NCT ID NCT06992869

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested three types of group psychological therapy for people with Parkinson's: one for adjusting to diagnosis, one for anxiety and depression, and one for memory and thinking problems. 138 participants took part, and the therapy was designed to be delivered by non-mental-health professionals. The goal was to see if it improves mood, quality of life, and coping, while also being cost-effective for the healthcare system.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
group-based psychological therapy
What this could lead to
If successful, this could provide a simple, low-cost mental health program for people with Parkinson's that can be delivered by non-specialists, improving quality of life and reducing hospital visits.
What could go wrong
This is a small pilot study (138 participants) with no control group, so results may not be generalizable. The therapy may not be effective for everyone, and long-term benefits are unknown.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PARKINSON'S DISEASE (PD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University College London

    London, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.